These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27147390)

  • 1. Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile.
    Cardoso CS; Sabino EC; Oliveira CD; de Oliveira LC; Ferreira AM; Cunha-Neto E; Bierrenbach AL; Ferreira JE; Haikal DS; Reingold AL; Ribeiro AL
    BMJ Open; 2016 May; 6(5):e011181. PubMed ID: 27147390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Score for Predicting 2-Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi-Trop Cohort Study.
    Di Lorenzo Oliveira C; Nunes MCP; Colosimo EA; de Lima EM; Cardoso CS; Ferreira AM; de Oliveira LC; Moreira CHV; Bierrenbach AL; Haikal DSA; Peixoto SV; Lima-Costa MF; Sabino EC; Ribeiro ALP
    J Am Heart Assoc; 2020 Mar; 9(6):e014176. PubMed ID: 32157953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between typical electrocardiographic abnormalities and NT-proBNP elevation in a large cohort of patients with Chagas disease from endemic area.
    Brito BOF; Pinto-Filho MM; Cardoso CS; Di Lorenzo Oliveira C; Ferreira AM; de Oliveira LC; Gomes P; Nunes MDCP; Sabino EC; Ribeiro ALP
    J Electrocardiol; 2018; 51(6):1039-1043. PubMed ID: 30497727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined measurement of N-terminal pro-B-type natriuretic peptide and highly sensitive cardiac troponin T for diagnosis and monitoring of heart injury in chronic Chagas' disease.
    Munoz Saravia SG; Haberland A; Bartel S; Araujo R; Valda G; Reynaga DD; Ramirez ID; Borges AC; Wallukat G; Ziebig R; Schimke I
    Clin Biochem; 2013 Oct; 46(15):1615-8. PubMed ID: 23810852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of cardiovascular biomarkers according to severity stages of Chagas cardiomyopathy.
    Echeverría LE; Rojas LZ; Calvo LS; Roa ZM; Rueda-Ochoa OL; Morillo CA; Muka T; Franco OH
    Int J Cardiol; 2017 Jan; 227():577-582. PubMed ID: 27839809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study.
    Cardoso CS; Ribeiro ALP; Oliveira CDL; Oliveira LC; Ferreira AM; Bierrenbach AL; Silva JLP; Colosimo EA; Ferreira JE; Lee TH; Busch MP; Reingold AL; Sabino EC
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006814. PubMed ID: 30383777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cohort profile update: the main and new findings from the SaMi-Trop Chagas cohort.
    Oliveira CDL; Cardoso CS; Baldoni NR; Natany L; Ferreira AM; Oliveira LC; Nunes MDCP; Quintino ND; Bierrenbach AL; Buss LF; Haikal DS; Cunha Neto E; Ribeiro ALP; Sabino EC
    Rev Inst Med Trop Sao Paulo; 2021; 63():e75. PubMed ID: 34586309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of NT-proBNP for Early Identification of Chagas Cardiomyopathy in Non-endemic Areas.
    Merás P; Caro J; Trigo E; Irazusta J; López-Sendón JL; Refoyo E
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):783-785. PubMed ID: 28238648
    [No Abstract]   [Full Text] [Related]  

  • 10. Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil.
    Ferreira AM; Sabino EC; de Oliveira LC; Oliveira CD; Cardoso CS; Ribeiro AL; Haikal DS
    PLoS One; 2016; 11(11):e0165950. PubMed ID: 27855177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers and mortality in severe Chagas cardiomyopathy.
    Sherbuk JE; Okamoto EE; Marks MA; Fortuny E; Clark EH; Galdos-Cardenas G; Vasquez-Villar A; Fernandez AB; Crawford TC; Do RQ; Flores-Franco JL; Colanzi R; Gilman RH; Bern C
    Glob Heart; 2015 Sep; 10(3):173-80. PubMed ID: 26407513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
    Greene SJ; Maggioni AP; Fonarow GC; Solomon SD; Böhm M; Kandra A; Prescott MF; Reimund B; Hua TA; Lesogor A; Zannad F; Gheorghiade M;
    Eur J Heart Fail; 2015 Jan; 17(1):98-108. PubMed ID: 25597870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study.
    Mishra RK; Judson G; Christenson RH; DeFilippi C; Wu AHB; Whooley MA
    Cardiology; 2017; 137(4):201-206. PubMed ID: 28445886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.
    Morillo CA; Marin-Neto JA; Avezum A; Sosa-Estani S; Rassi A; Rosas F; Villena E; Quiroz R; Bonilla R; Britto C; Guhl F; Velazquez E; Bonilla L; Meeks B; Rao-Melacini P; Pogue J; Mattos A; Lazdins J; Rassi A; Connolly SJ; Yusuf S;
    N Engl J Med; 2015 Oct; 373(14):1295-306. PubMed ID: 26323937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
    Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
    Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The third and new face of Chagas disease].
    Pays JF
    Bull Soc Pathol Exot; 2016 Aug; 109(3):139-42. PubMed ID: 27376642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle.
    Barbosa MM; Nunes Mdo C; Ribeiro AL; Barral MM; Rocha MO
    Eur J Echocardiogr; 2007 Jun; 8(3):204-12. PubMed ID: 16651029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.
    Nadrowski P; Chudek J; Grodzicki T; Mossakowska M; Skrzypek M; Wiecek A; Zdrojewski T; Kozakiewicz K
    Exp Gerontol; 2013 Sep; 48(9):852-7. PubMed ID: 23770107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.